Monoclonal Antibodies Could Add Power to CLL Treatment

Andrew Schorr from Patient Power in partnership with the CLL Global Research Foundation interview Dr. Thomas Kipps, Director of the Blood Cancer Research Fund and the CLL Research Consortium about the use of rituximab, a monoclonal antibody used to treat patients with chronic lymphocytic leukemia

Clink here to watch the video now!

Developmental Protein Plays a Role in Spread of Cancer

http://health.ucsd.edu/news/releases/Pages/2013-06-14-developmental-protein-plays-cancer-role.aspx

Dr. Thomas Kipps and scientists from his research laboratory at the UC San Diego Moores Cancer Center discover an association between a protein called ROR1 and EMT, a process that occurs during embryogenesis.

Read the above article to learn more!